Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1988 | 12-1987 | 12-1986 | 12-1985 | 12-1984 | |
| Sales | 3,607,400 | 3,643,800 | 3,322,500 | 2,918,700 | 3,109,200 |
| Cost of Goods | 1,125,300 | 1,302,800 | 1,224,700 | 1,077,600 | 1,128,400 |
| Gross Profit | 2,732,900 | 2,341,000 | 2,374,200 | 2,095,200 | 1,980,800 |
| Operating Expenses | 1,560,600 | 1,758,100 | 1,268,600 | 1,120,500 | 1,236,900 |
| Operating Income | 921,800 | 583,700 | 829,900 | 721,200 | 744,300 |
| Interest Expense | 0 | 0 | 0 | 0 | 43,100 |
| Other Income | 158,900 | 11,300 | 13,500 | 30,700 | 69,500 |
| Pre-tax Income | 1,080,700 | 595,000 | 843,400 | 751,900 | 770,700 |
| Income Tax | 319,700 | 184,500 | 301,900 | 258,300 | 280,500 |
| Net Income Continuous | 761,000 | 410,500 | 541,500 | 493,600 | 490,200 |
| Net Income Discontinuous | 0 | 233,200 | 16,700 | 24,000 | 0 |
| Net Income | $761,000 | $643,700 | $558,200 | $517,600 | $490,200 |
| EPS Basic Total Ops | 0.69 | 0.58 | 0.50 | 0.46 | 0.42 |
| EPS Basic Continuous Ops | 0.69 | 0.37 | 0.46 | 0.22 | 0.43 |
| EPS Basic Discontinuous Ops | N/A | 0.21 | 0.01 | 0.01 | N/A |
| EPS Diluted Total Ops | 0.69 | N/A | 0.48 | 0.23 | 0.43 |
| EPS Diluted Continuous Ops | 0.69 | N/A | 0.46 | 0.22 | 0.43 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.01 | 0.01 | N/A |
| EBITDA(a) | $1,125,800 | $794,000 | $1,007,600 | $721,200 | $744,300 |